Skip to main content

What the FDA labels say about taking them together

Cytarabine and palonosetron

Palonosetron's FDA label (Palonosetron Hydrochloride) of January 13, 2022 names cytarabine in its drug interactions section; the cytarabine label PlainMeds reads does not name palonosetron.

Check it at the source: the cytarabine FDA label on DailyMed (effective April 7, 2025, Hospira, Inc.); the palonosetron FDA label on DailyMed (effective April 29, 2025, Avyxa Pharma, LLC).

What does the cytarabine label say about palonosetron?

Cytarabine's label (effective April 7, 2025) does not name palonosetron in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Cytarabine), Hospira, Inc., effective April 7, 2025 (SPL set e3a8c0e9-19ed-49b7-8464-11e8806f47fd), via openFDA; the full label on DailyMed

What does the palonosetron label say about cytarabine?

Palonosetron Hydrochloride label (Cipla USA Inc., January 13, 2022), drug interactions

Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, cytarabine, doxorubicin and mitomycin C) in murine tumor models.

Source: FDA drug label (Palonosetron Hydrochloride, NDA021372), Cipla USA Inc., effective January 13, 2022 (SPL set 37e7ef89-fd77-44e0-9271-ae91f8822603), via openFDA

Source: FDA drug label (posfrea), Avyxa Pharma, LLC, effective April 29, 2025 (SPL set 13a201ba-c86d-48c5-a0e1-a3e0b4e6a2a7), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Cytarabine generic labelers
13Palonosetron generic labelers
CytarabinePalonosetron
Labeled forLeukemia, lymphoma and myelomaNausea and vomiting
Boxed warningYesNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?